HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy

Anti-HER2/neu antibody therapy has been reported to mediate tumor regression of HER2/ neu(+) tumors. Here we demonstrated the expression of HER2 in a wide range of human melanoma cells including a primary culture and seven cell lines, and we further investigated whether HER2 could be served as a tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Juan, Han, Huamin, Liu, Deruo, li, Wei, Feng, Hongxiang, Xue, Xin, Wu, Xiaoran, Niu, Ge, Zhang, Ge, Zhao, Yunfeng, Liu, Changzhen, Tao, Hua, Gao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754977/
https://www.ncbi.nlm.nih.gov/pubmed/24015299
http://dx.doi.org/10.1371/journal.pone.0073261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754977/
https://www.ncbi.nlm.nih.gov/pubmed/24015299
http://dx.doi.org/10.1371/journal.pone.0073261

Ejemplares similares